Notas del episodio
In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9 for improved diagnosis and monitoring. Expert insights explore new findings on liver and lung pathology in MAS, as well as updates on therapeutic innovations, including JAK inhibitors and emapalumab, and their roles in enhancing patient outcomes. Practical strategies are provided for integrating the latest research and cutting-edge diagnostics into clinical practice.
Launch Date: December 19, 2024
Release Date: December 19, 2024
Expiration Date: November 30, 2025
FACULTY
Pui Lee, MD
Assistant Professor of Pediatrics
Boston Children's Hospital
Alexe ...